Deep neuromuscular block with pipecuronium in patients undergoing laparoscopic surgery - A prospective case series.

L��szl�� Asztalos, Zolt��n Szab��-Ma��k, Mariann Berh��s, Zsolt Kany��ri, Gy��rgy Nagy, Adrienn Pongr��cz, R��ka Nemes, Sorin J Brull, B��la F��lesdi
Author Information
  1. L��szl�� Asztalos: Department of Anesthesiology and Intensive Care, University of Debrecen, Faculty of Medicine, Debrecen, Hungary.
  2. Zolt��n Szab��-Ma��k: Department of Anesthesiology and Intensive Care, University of Debrecen, Faculty of Medicine, Debrecen, Hungary.
  3. Mariann Berh��s: Department of Anesthesiology and Intensive Care, University of Debrecen, Faculty of Medicine, Debrecen, Hungary.
  4. Zsolt Kany��ri: Department of Surgery, University of Debrecen, Faculty of Medicine, Hungary.
  5. Gy��rgy Nagy: Department of Anesthesiology and Intensive Care, University of Debrecen, Faculty of Medicine, Debrecen, Hungary.
  6. Adrienn Pongr��cz: Department of Anesthesiology and Intensive Care, University of Debrecen, Faculty of Medicine, Debrecen, Hungary.
  7. R��ka Nemes: Department of Anesthesiology and Intensive Care, University of Debrecen, Faculty of Medicine, Debrecen, Hungary.
  8. Sorin J Brull: Mayo Clinic College of Medicine and Science, Jacksonville, FL, United States.
  9. B��la F��lesdi: Department of Anesthesiology and Intensive Care, University of Debrecen, Faculty of Medicine, Debrecen, Hungary. Electronic address: fulesdi@med.unideb.hu.

Abstract

INTRODUCTION: We tested the feasibility of maintaining low intraabdominal pressures during pipecuronium-induced deep block (post-tetanic count ���1, train-of-four count���=���0) in patients undergoing laparoscopic surgery.
METHODS: Ten adult patients awaiting cardiac surgery or heart transplantation and requiring non-elective abdominal surgery were included. Pipecuronium bromide 0.09���mg/kg was used for muscle relaxation and maintenance of deep block. Top-up doses of pipecuronium (0.01-0.02���mg/kg) were administered when post-tetanic count was 4-8. Intraabdominal pressures were kept below 10���mmHg. Mean arterial pressure was measured intra-arterially. Surgical field view was rated on a 5-point scale (1���=���extremely poor, 5���=���optimal).
RESULTS: Induction dose of 0.09���mg/kg pipecuronium had an onset time of 5.3 (2.3-6.3, 25-75% IQR)���min. Deep block was maintained for 51.2��������19.7���min. Top-up pipecuronium doses were necessary in 5 patients, 56.0��������28.1���min after the first dose. At the end of surgery, neuromuscular block was deep (post-tetanic count 0-6). Administration of 2���mg/kg of sugammadex induced recovery to train-of-four ratio ���0.9 in 3.5��������1.6���min, and to train-of-four ratio���=���1.0 in 4.3��������1.2���min. Mean intraabdominal pressure was 8.1��������1.1���mmHg during pneumoperitoneum. There was no significant change in heart rate (0.0, -2.6 to 0)���beats/min.
DISCUSSION: Pipecuronium is a rational alternative when deep neuromuscular block is necessary, because of its long-acting neuromuscular blocking effect that may be antagonized quickly and safely with sugammadex.
REGISTRATION: European Clinical Trials Database registration number: 2022-004114-11, Clinical Trials Database registration number: NCT06517524.

Keywords

Associated Data

ClinicalTrials.gov | NCT06517524

Word Cloud

Created with Highcharts 10.0.0block0surgeryneuromusculardeeppatientspipecuroniumpost-tetaniccounttrain-of-fourPipecuronium3Deepintraabdominalpressuresundergoinglaparoscopicheartbromide09���mg/kgTop-updosesMeanpressuredose5necessarysugammadexClinicalTrialsDatabaseregistrationnumber:INTRODUCTION:testedfeasibilitymaintaininglowpipecuronium-induced���1count���=���0METHODS:Tenadultawaitingcardiactransplantationrequiringnon-electiveabdominalincludedusedmusclerelaxationmaintenance01-002���mg/kgadministered4-8Intraabdominalkept10���mmHgarterialmeasuredintra-arteriallySurgicalfieldviewrated5-pointscale1���=���extremelypoor5���=���optimalRESULTS:Inductiononsettime23-625-75%IQR���minmaintained512��������197���min560��������281���minfirstend0-6Administration2���mg/kginducedrecoveryratio���095��������16���minratio���=���143��������12���min81��������11���mmHgpneumoperitoneumsignificantchangerate-26���beats/minDISCUSSION:rationalalternativelong-actingblockingeffectmayantagonizedquicklysafelyREGISTRATION:European2022-004114-11NCT06517524-prospectivecaseseriesLaparoscopicSugammadex

Similar Articles

Cited By

No available data.